Morgan Stanley upgraded Pidilite Industries Ltd. and Navin Fluorine International to 'overweight' and 'equal weight' ratings after noting their exposure to agrochemicals. Indian chemical companies will see a constructive volume-growth cycle led by agrochemicals in financial year 2026, according to the brokerage.
It hiked the target price for Pidilite Industries to Rs 5,000 from Rs 3,524 apiece, which implies a 65% upside from current levels. For Navin Fluorine, the target price was raised to Rs 4,160 apiece, from Rs 3,242 apiece. The current target price implies a 8.4% downside from current price.
The cycle will likely support stronger asset runs and operating leverage-led margin tailwinds against demand challenges and weak pricing. This turn in the cycle is expected to herald stronger orderbook growth, faster capacity monetisation, operating -leverage-led margin tailwinds, Morgan Stanley said.
A fresh round of global crop protection volume growth in 2026 and 2027 will likely have multiple implications for India chemicals. Agrochemicals constitute 30–35% revenue across India's specialty chemical portfolios, and exports comprises about half of revenues. Indian chemical producers are the incumbent beneficiaries as legacy offtakes improve, and new products scale up, Morgan Stanley said. Competitive pressures should ease, according to the brokerage.
It estimates double-digit volume growth, underpinning a return to 20% CAGR earnings growth profiles. There is also likely to be 200 basis points rise in return on capital employed, according to the brokerage.
Key risks for Indian chemical companies are volume uptick remaining elusive, which may compound pricing pressures, and delay monetisation and returns expansion, Morgan Stanley said in the note.
Morgan Stanley raised the valuation multiple for Pidilite Industries' agrochemicals segment to 23 times, and increased segment earnings estimates by 7%. According to the brokerage, Pidilite Industries will see a three-pronged volume increase across domestic, exports, and new molecules.
The brokerage also raised the valuation multiple for Navin Fluorine International's contract manufacturing and high performance segment to 25 times, compared to 22 times earlier. This reflects Navin Fluorine International's strong execution across operational efficiency, margin improvement, and order book expansion.
RECOMMENDED FOR YOU

Leela Hotels Has Morgan Stanley 'Overweight' On Luxury Demand, Attractive Valuation

.jpg?rect=0%2C0%2C3500%2C1969&w=75)
Navin Fluorine Opens QIP Worth Rs 750 Crore, Fixes Floor Price


Chalk And Cheese: Godrej Consumer Q1 Update Has Morgan Stanley Bullish; Macquarie Cautious


Nykaa Shares Gain As Morgan Stanley Is 'Overweight' Post Q1 Business Update
